Previous studies indicated that IGFBP7 functions as a tumor suppressor in several tumors, including hepatocellular carcinoma, colorectal carcinoma, prostate cancer cells, and breast cancer (17, 48–50). Here, IGFBP7 is linked to prostate cancer.